Michael Gallo - Medical Innovation Director
Director
Mr. Michael Gallo is no longer Director of Medina International Holdings Inc. effective June 10 2016. Mr. Gallo began his professional career as an Officer in the United States Air Force managing Military Airlift Command facility design and operations at Norton Air Force Base in San Bernardino California. In 1989 Mr. Gallo served as the Director of Program Control for the TRW Launch Services Organization. In 1993 Mr. Gallo cofounded Kelly Space Technology Inc. a commercial Reusable Launch Vehicle aerospace energy and homeland security technology development company where he serves as President and Chief Executive Officer. Mr. Gallo also serves as a Director for Global Energy Systems LLC KST subsidiary formed to implement its energyrelated lines of business. Mr. Gallo provides leadership to the commercial civil and military space community as a founding member the past Chairman and current Chief Financial Officer of the California Space Authority an organization that serves as the space policy advisor to the State of California and represents California diverse space enterprise community. Mr. Gallo also serves as the Arrowhead Section Chairman of the American Institute of Aeronautics and Astronautics . Mr. Gallo is the past Chairman and current Vice Chairman of the Community Action Partnership of San Bernardino County providing key services and support to our low income community. since 2008.
| Age | 55 |
| Tenure | 16 years |
| Phone | 866-883-3793 |
| Web | http://medicalinnovationholdings.com |
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Betsy Holden | Diageo PLC ADR | 63 | |
| Daniel Hanrahan | Cedar Fair LP | 62 | |
| Thomas Klein | Cedar Fair LP | 53 | |
| Eric Affeldt | Cedar Fair LP | 58 | |
| Ireena Vittal | Diageo PLC ADR | 51 | |
| Victoria Frame | Diageo PLC ADR | 44 | |
| John Scott | Cedar Fair LP | 53 | |
| John Krumins | Playtech plc | N/A | |
| Debra SmithartOglesby | Cedar Fair LP | 65 | |
| Lauri Shanahan | Cedar Fair LP | 57 | |
| Charlotte Lambkin | Diageo PLC ADR | 43 | |
| Ian Penrose | Playtech plc | 50 | |
| John Manzoni | Diageo PLC ADR | N/A | |
| John Jackson | Playtech plc | 55 | |
| Anna Manz | Diageo PLC ADR | 42 | |
| Ron Hoffman | Playtech plc | 38 | |
| Valerie ChapoulaudFloquet | Diageo PLC ADR | 58 | |
| Andrew Thomas | Playtech plc | 75 | |
| Daniel Mobley | Diageo PLC ADR | 40 | |
| Anna Massion | Playtech plc | 39 | |
| Ursula Burns | Diageo PLC ADR | 59 | |
Medical Innovation Leadership Team
Elected by the shareholders, the Medical Innovation's board of directors comprises two types of representatives: Medical Innovation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medical. The board's role is to monitor Medical Innovation's management team and ensure that shareholders' interests are well served. Medical Innovation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medical Innovation's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Stol, Director | ||
| Redgie Green, Director | ||
| Arturo Sanchez, CEO | ||
| Bart Siegel, Director | ||
| Raymond Demotte, CFO, Director | ||
| Lawrence Litowitz, Interim CFO | ||
| Madhava Mankal, CFO and Director | ||
| Daniel Medina, CEO and President and Director | ||
| John Lewis, Director | ||
| Raimundo Dias, President Corporate Secretary, Director | ||
| Michael Gallo, Director |
Medical Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Medical Innovation a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 567.7 K | |||
| Shares Outstanding | 39.88 M | |||
| Shares Owned By Insiders | 0.20 % | |||
| Price To Earning | (22.61) X | |||
| Price To Sales | 4.15 X | |||
| Revenue | 48 K | |||
| Net Income | (1.43 M) | |||
| Cash And Equivalents | 6.46 K | |||
| Total Debt | 514.34 K | |||
| Book Value Per Share | (0.04) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medical Innovation in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medical Innovation's short interest history, or implied volatility extrapolated from Medical Innovation options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Medical Innovation information on this page should be used as a complementary analysis to other Medical Innovation's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Medical OTC BB Equity
If you are still planning to invest in Medical Innovation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medical Innovation's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |